Recolony is a Swiss biotech start-up that wants to create an oral medication based on bacteria that can both treat and prevent cancer. A microbial-based treatment for colorectal cancer is called recolony.
Colorectal cancer, Biotechnology, Prevent Cancer
No funding announced yet
💡 You're a corporate or investor and looking for startups that are innovating in the same market as Recolony? We're happy to assist you with our Startup Sourcing service.